Dr. Alexis Chiang Colvin is an Associate Professor of Sports Medicine at Mount Sinai Hospital in the Leni and Peter W. May Department of Orthopaedic Surgery. A graduate of Princeton University, she received her medical degree from Mount Sinai and completed her orthopaedic surgery residency at NYU Hospital for Joint Diseases. During her residency, Dr. Colvin was selected for one of the most prestigious Sports Medicine Fellowships in the country at the University of Pittsburgh Medical Center in Pittsburgh, PA. While in Pittsburgh, Dr. Colvin cared for professional athletes, including the Pittsburgh Steelers and Penguins, collegiate athletes at the University of Pittsburgh, and numerous other collegiate and high school athletes.
Dr. Colvin specializes in the surgical treatment of knee, shoulder, and hip disorders. She has authored numerous scientific publications and has presented both at national and international meetings on sports medicine and orthopaedic surgery. Dr Colvin is a board certified orthopaedic surgeon and member of the American Academy of Orthopaedic Surgeons, The American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America and International Society for Hip Arthroscopy. Dr Colvin is the Chief Medical Officer for the United States Tennis Association, the team physician for the US Fed Cup team, and serves as a physician at the U.S. Open. Dr Colvin has also served as a physician at the US Olympic Training Center in Colorado Springs, CO.
Dr. Colvin has been nationally recognized as a leader in the field of orthopaedics: http://beckersorthopedicandspine.com/lists/item/9583-70-female-orthopedic-and-spine-surgeon-leaders-to-know and was selected as a NY Magazine Top Doctor 2016.
American Board of Orthopaedic Surgery
MD, Mount Sinai School of Medicine
Hospital For Joint Diseases
Fellowship, Sports Medicine
University of Pittsburgh Medical Center
Chinese (Mandarin), English, Spanish
New York Magazine
Super Doctors Rising Stars
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Colvin did not report having any of the following types of financial relationships with industry during 2016 and/or 2017: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.